Revive Bio-Technology Private Limited
About Revive Bio-Technology Private Limited
Data last updated:
Revive Bio-Technology Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Revive Impex Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the real estate financing segment of the financial services sector. It was incorporated on 13 December 2004.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC044858.
The company had an authorised share capital of ₹1 Cr and a paid-up capital of ₹90.9 Lakh. It was led by directors Snigdha Reddy Chada and Phaneshwar Katangur.
Its last annual general meeting (AGM) was held on 05 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at Plot No.25 To 30 Phase V Ida Cherlapally, Hyderabad, Telangana, India – 500051.
As per the financials filed for FY 2022, the company reported a revenue of ₹12.83 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹42,743 (net margin 3.3%) and EBITDA of ₹8.38 Lakh (EBITDA margin 65.3%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 32% over five years.
Company details
CIN history
Revive Bio-Technology has one previous CIN (Corporate Identification Number): U24239AP2004PTC044858. The current CIN is U24239TG2004PTC044858, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC044858 | Current |
| U24239AP2004PTC044858 | Previous |
Contact details
Revive Bio-Technology Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.25 To 30 Phase V Ida Cherlapally, Hyderabad, Telangana, India – 500051
- IndustryFinancial Services, Real Estate Financing
To see the full contact details of Revive Bio-Technology Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Revive Bio-Technology Private Limited
FY 2022 filings availableRevive Bio-Technology Private Limited reported revenue of ₹12.83 Lakh (up 7% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 7% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.38 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹42,743 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 65.3% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Revive Bio-Technology Private Limited, buy the company report.
Board of directors of Revive Bio-Technology Private Limited
Revive Bio-Technology has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Snigdha Reddy Chada Also directs: Karthik Eco Technologies Private Limited | Director | 01 Aug 2015 | 11 Years 2 Months | As last reported |
| Phaneshwar Katangur Also directs: Karthik Eco Technologies Private Limited | Director | 01 Aug 2015 | 11 Years 2 Months | As last reported |
Peer comparison
Revive Bio-Technology Private Limited is compared with the 10 companies closest to it by revenue in the BFSI industry (Real Estate Leasing), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mallika Investment Co Pvt Ltd | ₹12.85 Lakh (FY 2025) | 16.0% | Kolkata, West Bengal, India | |||
| Din Dayal and Sons Private Limited | ₹12.85 Lakh (FY 2023) | 4.0% | New Delhi, Delhi, India | |||
| Saikrish Capital Private Limited | ₹12.85 Lakh (FY 2025) | 1.0% | Mumbai, Maharashtra, India | |||
| Stylish Tie Up Pvt Ltd | ₹12.85 Lakh (FY 2025) | 52.0% | Kolkata, West Bengal, India | |||
| House King Developers Private Limited | ₹12.85 Lakh (FY 2024) | -83.0% | Navi Mumbai, Maharashtra, India | |||
| Revive Bio-Technology Private Limitedthis company | ₹12.83 Lakh (FY 2022) | ₹42,743 | 3.3% | 7.0% | Hyderabad, Telangana, India | |
| Kiran Properties Private Limited | ₹12.83 Lakh (FY 2025) | 0.0% | Delhi, India | |||
| Citizen Developers Private Limited | ₹12.82 Lakh (FY 2025) | 39.0% | New Delhi, Delhi, India | |||
| Geo Jute Limited | ₹12.82 Lakh (FY 2024) | 66.0% | Kanpur, Uttar Pradesh, India | |||
| Bengal Marbles & Tiles Private Limited | ₹12.82 Lakh (FY 2024) | 158.0% | Kolkata, West Bengal, India | |||
| Tiger Hill Hotels & Properties Ltd | ₹12.81 Lakh (FY 2025) | -6.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Revive Bio-Technology Private Limited, buy the company report.
Auditor
Revive Bio-Technology Private Limited is audited by K.S.S.GANGADHAR & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.S.S.GANGADHAR & CO | FY 2017 | 008692S |
Shareholding
The shareholding of Revive Bio-Technology Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Revive Bio-Technology Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Revive Bio-Technology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Revive Bio-Technology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Revive Bio-Technology Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Revive Bio-Technology Private Limited has 8 board changes on record since 2015: 2 appointments and 6 cessations. The latest: Ramesh Reddy Chada ceased to be Director on 23 Mar 2021.
Frequently asked questions
Revive Bio-Technology has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Revive Bio-Technology was a private limited company based in Hyderabad, Telangana, India. The company worked in real estate financing, within the financial services industry. It was incorporated on 13 December 2004 and is registered under CIN U24239TG2004PTC044858. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Revive Bio-Technology was incorporated on 13 December 2004. It is registered with the Registrar of Companies, Hyderabad.
Revive Bio-Technology had 2 directors:
- Snigdha Reddy Chada - Director
- Phaneshwar Katangur - Director
The CIN (Corporate Identification Number) of Revive Bio-Technology is U24239TG2004PTC044858. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Revive Bio-Technology is at Plot No.25 To 30 Phase V Ida Cherlapally, Hyderabad, Telangana, India – 500051.
The latest financial statements of Revive Bio-Technology on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 05 September 2022. Year-wise statements from 2015 are in the company report.
Revive Bio-Technology operated in the financial services industry, in the real estate financing segment.
The peers of Revive Bio-Technology by revenue are Mallika Investment Co Pvt Ltd, Din Dayal and Sons Private Limited, Saikrish Capital Private Limited, Stylish Tie Up Pvt Ltd, House King Developers Private Limited and 5 more, all in the BFSI industry (Real Estate Leasing).
Ramesh Reddy Chada ceased to be Director on 23 Mar 2021. Ratna Rao Vissa ceased to be Director on 27 May 2016. Venkatasubbarao Potluri ceased to be Director on 27 May 2016. Revive Bio-Technology has 8 board changes on record in total.
The compliance status of Revive Bio-Technology is compliant as of 20 July 2026.